# Herceptin Hylecta

NDC: 50242-077
Generic name: Trastuzumab and hyaluronidase-oysk
Labeler / Manufacturer: Genentech, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20190228

FDA application: BLA761106

## Active ingredients

- HYALURONIDASE (HUMAN RECOMBINANT): 10000 U/5mL
- TRASTUZUMAB: 600 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"50242-077"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=50242-077
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=ebf30894-41cf-480c-8bc3-56f592a13813